Modulation of Microvascular Hydraulic Permeability by Platelet-Activating Factor

Journal of Trauma - Injury, Infection and Critical Care

Volumn 56, Issue 2, 2004, Pages 379-384

  Victorino, Gregory P ^a,b   Newton, Christopher R ^a   Curran, Brian ^a  

^a ALAMEDA COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dose response; Hydraulic conductivity; Microvascular permeability; Platelet activating factor

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL OCCLUSION; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; EDEMA; ERYTHROCYTE; FEMALE; HYDRAULIC PERMEABILITY; HYDROSTATIC PRESSURE; INFLAMMATION; LEUKOCYTE ACTIVATION; MICROVASCULATURE; NONHUMAN; ONCOTIC PRESSURE; PRIORITY JOURNAL; RAT; SHOCK; SYRIAN HAMSTER; VASCULAR ENDOTHELIUM; VENULE;

EID: 1542376554     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000042156.89779.6C     Document Type: Article

References (22)

1. Pinckard RN, McManus LM, Hanahan DJ. Chemistry and biology of acetyl glyceryl ether phosphorylcholine (platelet-activating factor). In: Weissmann G, ed. Advances in Inflammation Research. Vol 4. New York: Raven Press; 1982:147-179.
2. Anderson BO, Denis DB, Harkin AH. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynecol Obstet. 1991;172:415-424.
3. Sirois MG, Jancar S, Braquet P, Plante GE, Sirois P. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. Prostaglandins. 1998;36:631-643.
4. Kubes P, Suzuki M, Granger DN. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. Am J Physiol. 1990;259:G859-G864.
5. Duran WN, Dillon PK. Acute microcirculatory effects of platelet activating factor. J Lipid Mediat. 1990;2(suppl):S215-S227.
6. Stahl GL, Craft DV, Lento PH, Lefer AM. Detection of platelet-activating factor during traumatic shock. Circ Shock. 1988;26:237-244.
7. Csaki C, Szabo C, Benyo Z, Kovach AGB. Role of platelet-activating factor in the development of endothelial dysfunction in hemorrhagic hypotension and retransfusion. Thromb Res. 1992;66:23-31.
8. Bjork J, Lindbom L, Gerdin B, Smedegard G, Arfors KE, Benveniste J. Paf-acether (platelet activating factor) increases microvascular permeability and affects endothelium-granulocyte interaction in microvascular beds. Acta Physiol Scand. 1983;119:305-308.
9. Clavijo LC, Carter MB, Matheson PJ, Wilson MA, Wead WB, Garrison RN. PAF increases vascular permeability without increasing pulmonary arterial pressure in the rat. J Appl Physiol 2001;90:261-268.
10. Lu Z, Wolf MB. Platelet activating factor-induced microvascular permeability increases in the cat hindlimb. Circ Shock. 1993;41:8-18.
11. Walther A, Yilmaz N, Schmidt W, et al. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia. J Surg Res. 2000;93:256-271.
12. Ramirez MM, Quardt SM, Kim D, Oshiro H, Minnicozzi M, Duran WN. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. Microvasc Res. 1995;50:223-234.
13. Curry FE, Huxley VH, Sarelius IH. Techniques in microcirculation: measurement of permeability, pressure and flow. In: Linden RT, ed. Cardiovascular Physiology: Techniques in the Life Sciences. Vol P309(1). New York: Elsevier; 1983:1-34.
14. Michel CC, Curry FE. Microvascular permeability. Physiol Rev. 1999;79:703-756.
15. Adamson RH, Liu B, Fry GN, Rubin LL, Curry FE. Microvascular permeability and number of tight junctions are modulated by cAMP. Am J Physiol. 1998;274(6 pt 2):H1885-H1894.
16. Buonassisi V, Venter JC. Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proc Natl Acad Sci USA. 1976;73:1612-1616.
17. He P, Liu B, Curry FE. Effect of nitric oxide synthase inhibitors on endothelial [Ca2+]i and microvessel permeability. Am J Physiol. 1997;272:H176-H185.
18. He P, Zeng M, Curry FE. cGMP modulates basal and activated microvessel permeability independently of Ca+. Am J Physiol. 1998;274(6 pt 2):H1865-H1874.
19. Boussolino F, Camussi G. Platelet activating factor produced by endothelial cells: a molecule with autocrine and paracrine properties. Eur J Biochem. 1995;229:327-337.
20. O'Brien JG, Farmer P, Battistini B, Johnson RJ, Zaharia F, Sirois P. Effects of tranexamic acid and aprotinin on PAF-induced vascular permeability in normal, thrombocytopenic or neutropenic rats. Inflamm Res. 1997;46(suppl 2):s145-s146.
21. He P, Wang J, Zeng M. Leukocyte adhesion and microvessel permeability. Am J Physiol. 2000;278:H1686-H1694.
22. Childs EW, Smalley DM, Moncure M, Miller JL, Cheung LY. Effect of WEB-2086 on leukocyte adherence in response to hemorrhagic shock in rats. J Trauma. 2000;49:1102-1107.